Amerikaanse aandelen Terug naar discussie overzicht

Forum Transenterix geopend

1. Hulskof 22 januari 2021 20:59

   auteur info

   • Hulskof

     Lid sinds: 17 apr 2018

     Laatste bezoek: 28 apr 2024

   • Aanbevelingen

     Ontvangen: 1157

     Gegeven: 283

   •    Aantal posts: 3.591

   quote:

   Workhorse Fan schreef op 22 januari 2021 08:57:

   Zou het dan toch nog iets worden????
   

   Ik vrees van niet. Koers is wederom erg vooruitgelopen op de behaalde resultaten, die nog altijd ver benedenmaats zijn. Ze hebben al in geen jaren een bot verkocht, ze leasen ze nu. En op de instrumenten verdienen ze ook al niet veel, omdat die meermaals herbruikt kunnen worden, itt die van Intuitive Surgical. Leuke pump, de afgelopen dagen, maar ik geloof er niet (meer) in.
2. Sens Boy 23 januari 2021 12:55

   auteur info

   • Sens Boy

     Lid sinds: 21 mei 2018

     Laatste bezoek: 19 jun 2023

   • Aanbevelingen

     Ontvangen: 9

     Gegeven: 5

   •    Aantal posts: 135

   Als je de omzetten op de beurs van de laatste 3 weken, volgt zie je enorme omzetten. Dit heeft een oorzaak, vraag me niet welke maar je ziet telkens transacties met duizenden aandelen, dit zijn echt geen particuliere investors. Intuitive is in principe monopolist maar ze zijn totaal niet geliefd bij de ziekenhuizen. Ik denk (hoop) dat we nog mooie dingen gaan zien de komende weken.
3. MarkvB 27 januari 2021 14:17

   auteur info

   • MarkvB

     Lid sinds: 15 nov 2016

     Laatste bezoek: 14 apr 2023

   • Aanbevelingen

     Ontvangen: 105

     Gegeven: 209

   •    Aantal posts: 339

   TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million
   
   TransEnterix, Inc. (NYSE American: TRXC) ("TransEnterix" or the "Company"), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 23,083,333 shares of common stock of the Company at a public offering price of $3.00 per share, less underwriting discounts and commissions. The Company also has granted the underwriter a 30-day option to purchase up to an additional 3,462,499 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 29, 2021, subject to customary closing conditions.
   
   H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.
   
   The gross proceeds of the offering are expected to be approximately $69.25 million, prior to deducting underwriting discounts and commissions and estimated offering expenses and excluding the exercise of the underwriter’s option to purchase additional shares. The Company intends to use the net proceeds from this offering for general corporate purposes, including working capital and funding research and development activities.
   
   The shares of common stock are being offered pursuant to an effective registration statement on Form S-3 (File No. 333-236200) that was filed with the U.S. Securities and Exchange Commission ("SEC") on January 31, 2020 and declared effective on February 10, 2020 and an additional registration statement on Form S-3 filed pursuant to Rule 462(b) and became automatically effective on January 26, 2021. The shares of common stock may be offered only by means of a prospectus. A preliminary prospectus supplement and accompanying prospectus relating to the offering were filed with the SEC and are available on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus supplement and accompanying prospectus relating to the offering, when filed, may be obtained from H.C. Wainwright & Co., LLC, 430 Park Avenue, New York, NY 10022, by email at placements@hcwco.com or by phone at (646) 975-6996.
   
   This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction.
4. Hulskof 27 januari 2021 17:48

   auteur info

   • Hulskof

     Lid sinds: 17 apr 2018

     Laatste bezoek: 28 apr 2024

   • Aanbevelingen

     Ontvangen: 1157

     Gegeven: 283

   •    Aantal posts: 3.591

   Ja, ze gaan gewoon door met verwateren. Zal nog lang zo gaan...